ArticleBlood cancer journal2025

Genotype-guided comparison of VEN/HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: a multicenter real-world study.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.